Logo image of POET

POET TECHNOLOGIES INC (POET) Stock Fundamental Analysis

NASDAQ:POET - Nasdaq - CA73044W3021 - Common Stock - Currency: USD

4.38  +0.04 (+0.92%)

Fundamental Rating

1

Overall POET gets a fundamental rating of 1 out of 10. We evaluated POET against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. POET has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, POET is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year POET has reported negative net income.
In the past year POET has reported a negative cash flow from operations.
POET had negative earnings in each of the past 5 years.
In the past 5 years POET always reported negative operating cash flow.
POET Yearly Net Income VS EBIT VS OCF VS FCFPOET Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

The Return On Assets of POET (-81.40%) is worse than 94.55% of its industry peers.
POET's Return On Equity of -274.04% is on the low side compared to the rest of the industry. POET is outperformed by 90.91% of its industry peers.
Industry RankSector Rank
ROA -81.4%
ROE -274.04%
ROIC N/A
ROA(3y)-149.67%
ROA(5y)-132.57%
ROE(3y)-289.59%
ROE(5y)-248.85%
ROIC(3y)N/A
ROIC(5y)N/A
POET Yearly ROA, ROE, ROICPOET Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

POET does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
POET Yearly Profit, Operating, Gross MarginsPOET Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K -100K

More info and screens

1

2. Health

2.1 Basic Checks

POET does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, POET has more shares outstanding
POET has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, POET has a worse debt to assets ratio.
POET Yearly Shares OutstandingPOET Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
POET Yearly Total Debt VS Total AssetsPOET Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

POET has an Altman-Z score of -2.33. This is a bad value and indicates that POET is not financially healthy and even has some risk of bankruptcy.
POET's Altman-Z score of -2.33 is on the low side compared to the rest of the industry. POET is outperformed by 79.09% of its industry peers.
POET has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
POET has a worse Debt to Equity ratio (0.34) than 64.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z -2.33
ROIC/WACCN/A
WACC8.18%
POET Yearly LT Debt VS Equity VS FCFPOET Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

A Current Ratio of 1.15 indicates that POET should not have too much problems paying its short term obligations.
The Current ratio of POET (1.15) is worse than 89.09% of its industry peers.
POET has a Quick Ratio of 1.15. This is a normal value and indicates that POET is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.15, POET is not doing good in the industry: 83.64% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.15
POET Yearly Current Assets VS Current LiabilitesPOET Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

POET shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -70.59%.
The Revenue for POET has decreased by -91.15% in the past year. This is quite bad
The Revenue for POET have been decreasing by -41.80% on average. This is quite bad
EPS 1Y (TTM)-70.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.38%
Revenue 1Y (TTM)-91.15%
Revenue growth 3Y-41.8%
Revenue growth 5YN/A
Sales Q2Q%-73.12%

3.2 Future

Based on estimates for the next years, POET will show a very strong growth in Earnings Per Share. The EPS will grow by 31.42% on average per year.
POET is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 1159.92% yearly.
EPS Next Y71.86%
EPS Next 2Y36.79%
EPS Next 3Y31.42%
EPS Next 5YN/A
Revenue Next Year7600%
Revenue Next 2Y2357.64%
Revenue Next 3Y1159.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
POET Yearly Revenue VS EstimatesPOET Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
POET Yearly EPS VS EstimatesPOET Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for POET. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for POET. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
POET Price Earnings VS Forward Price EarningsPOET Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
POET Per share dataPOET EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

POET's earnings are expected to grow with 31.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.79%
EPS Next 3Y31.42%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for POET!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

POET TECHNOLOGIES INC

NASDAQ:POET (5/8/2025, 1:18:41 PM)

4.38

+0.04 (+0.92%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)03-30 2025-03-30/amc
Earnings (Next)05-20 2025-05-20
Inst Owners7.22%
Inst Owner Change1.27%
Ins Owners0.62%
Ins Owner ChangeN/A
Market Cap341.99M
Analysts82.5
Price Target6.38 (45.66%)
Short Float %4.97%
Short Ratio3.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-350.31%
Min EPS beat(2)-569.93%
Max EPS beat(2)-130.68%
EPS beat(4)0
Avg EPS beat(4)-192.69%
Min EPS beat(4)-569.93%
Max EPS beat(4)-17.65%
EPS beat(8)2
Avg EPS beat(8)-97.18%
EPS beat(12)4
Avg EPS beat(12)-67.84%
EPS beat(16)7
Avg EPS beat(16)-51.28%
Revenue beat(2)0
Avg Revenue beat(2)-68.27%
Min Revenue beat(2)-93.46%
Max Revenue beat(2)-43.08%
Revenue beat(4)0
Avg Revenue beat(4)-83.87%
Min Revenue beat(4)-100%
Max Revenue beat(4)-43.08%
Revenue beat(8)1
Avg Revenue beat(8)-43.5%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.7%
PT rev (3m)4.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)19.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8260.64
P/FCF N/A
P/OCF N/A
P/B 16.53
P/tB 17.03
EV/EBITDA N/A
EPS(TTM)-0.87
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS0
BVpS0.26
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -81.4%
ROE -274.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-149.67%
ROA(5y)-132.57%
ROE(3y)-289.59%
ROE(5y)-248.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 345.45%
Cap/Sales 16856.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.15
Quick Ratio 1.15
Altman-Z -2.33
F-Score3
WACC8.18%
ROIC/WACCN/A
Cap/Depr(3y)216.1%
Cap/Depr(5y)184.86%
Cap/Sales(3y)5894.23%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.38%
EPS Next Y71.86%
EPS Next 2Y36.79%
EPS Next 3Y31.42%
EPS Next 5YN/A
Revenue 1Y (TTM)-91.15%
Revenue growth 3Y-41.8%
Revenue growth 5YN/A
Sales Q2Q%-73.12%
Revenue Next Year7600%
Revenue Next 2Y2357.64%
Revenue Next 3Y1159.92%
Revenue Next 5YN/A
EBIT growth 1Y-44.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-16.58%
EBIT Next 3Y40.56%
EBIT Next 5YN/A
FCF growth 1Y-81.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.17%
OCF growth 3YN/A
OCF growth 5YN/A